Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc

is 19.70%. TRIB's revenue for the same period is $77.18 million. The trailing-twelve-month profit margin at Meridian Bioscience Inc

is 16.83%. VIVO's ROE for the same period is 19.97%. The trailing-twelve-month profit margin at IDEXX Laboratories Inc

is 13.28%. IDXX's ROE for the same period is 29.04%. The trailing-twelve-month profit margin at Quidel Corporation

is 4.11%. QDEL's PEG ratio is 3.14.